Key Stocks to Watch This Friday: Vivendi, JCDecaux, Rubis, and 9 Other Annual Results
This Friday, 12 listed companies are on the agenda with their annual results for 2025, most of which were revealed last night. Here's an overview of the stocks to watch.
In the context of a significant restructuring, Vivendi SE published its annual accounts for 2025 yesterday. After a colossal loss of 6 billion euros the previous year, the media group has returned to profitability, a milestone closely monitored since the conglomerate's breakup.
Following a record year in revenue, STEF presented mixed results: the refrigerated transport specialist revealed yesterday a net result plummeting by 46% despite a record turnover of 5.1 billion euros. This dissociation between commercial growth and profitability will capture investors' attention.
Rubis also maintained a similar tone, marking a 30th consecutive dividend increase while reporting a 19% surge in net income. The petroleum products distributor thus confirms a rare consistency in shareholder remuneration.
JCDecaux unveiled its annual results yesterday, achieving a record cash flow of 343 million euros, while the margin reached 20.9%. The global leader in outdoor advertising appears to benefit from the recovery in urban and airport flows, which was reflected in a more than 5% increase in its share price yesterday.
Several more challenging results also caught attention. Gaumont published accounts yesterday heavily impacted by animation: the net loss jumped to 195 million euros, a significant deterioration for the century-old studio. In the renewable energy sector, Voltalia reported a net loss of 128 million euros despite achieving operational targets, a situation attributed in part to the abandonment of projects deemed unprofitable.
For Maurel et Prom, the reading of the 2025 annual accounts is equally nuanced: the net result has increased by 72%, but the EBITDA fell by 32%, showing persistent pressure on operational cash generation for the oil company. In biotech, Abionyx Pharma presented its annual accounts for 2025 yesterday: the company has 3.5 million euros in cash and is now focusing its hopes on a clinical program targeting sepsis.
In Dutch biotechnologies, Pharming Group revealed yesterday a 27% increase in revenues, driven by the commercial expansion of its flagship treatment. A potential for 1,800 new patients is also identified as a growth lever for the coming years.
More discreet but with an interesting profile, Fill Up Media published its annual results for 2025 yesterday: the agency specializing in gas station screens reported a 68% increase in its turnover and announced it has reached profitability for the first time. In software, Acteos published accounts marked by a 35% drop in turnover, a consequence of a transition to a SaaS model, but the net loss was halved, a sign of progressing restructuring.
Miliboo publishes its annual results for 2025 today. The online furniture specialist has already drawn attention with the announcement of a record turnover accompanied by the departure of its founding CEO.
